Targeting IGF-1 signaling pathways in gynecologic malignancies.
about
New perspectives on targeted therapy in ovarian cancerExpression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms.The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting ApproachesGanitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapyAnalysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.Differential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell LinesMiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1RInsulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control studyInsulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohortQuantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signalingMicrosatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancerDietary inflammatory index and ovarian cancer risk in a large Italian case-control study.Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells.Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression.BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancerPre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.TGFβ Controls Ovarian Cancer Cell ProliferationThe TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors.The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies.Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways
P2860
Q28082524-ED873B8E-1BF5-44BF-96FD-BBDEFB9320BEQ33598498-C9CF59BE-C5CF-468E-ABF4-35E8FA8BF04DQ33658023-CD948065-602A-41B3-BD2F-663F879F2E10Q34068827-A39787EE-672B-4FCE-B2AB-B4EDA466B98AQ34673597-5D17F1CE-8433-4A24-8031-02E93B85FA29Q34818399-2663ACB7-6B15-414E-BFE0-A215BC4F1DA1Q34978831-AAB72CBC-DF87-417F-8BDA-93B36CCEC192Q35000609-58DCA989-5DE2-4371-AC61-D1871DF9432EQ35064451-D88A0FAF-C0E0-4FAC-8541-D3510DBB4A07Q35598117-3DE4FAA3-0A38-459C-9738-AA176152CF7CQ35677731-A2D8E460-BD38-4A0F-A74B-B97054CBC645Q35918864-E32EF748-352C-4EED-A053-E22755E43B1DQ36101707-79E6954B-F66B-42C0-B976-30A141AC0999Q36931333-C8171493-DDFA-4FF2-88C8-CED4BBC0E427Q37047871-9009AD36-E86E-485C-9BED-5AE67E98F94BQ37112768-74CB4D2C-2A79-4132-8C60-254619B3E1CDQ37334160-19878EF9-3156-495C-AF35-FF65881D5FEEQ37694786-D28E4BB9-3AA8-495D-BA77-E88A52090B78Q37720033-EA777498-3881-49AC-AA09-B2C97C75E521Q38756834-2FE044E5-40CF-4C86-A5B6-ECE746FCBCE9Q38824206-125F29E0-A093-40C8-A4C3-1E8089E0E36FQ41573289-81025631-2D4D-4490-8808-A601063167BDQ51703872-6B6C45A3-ED03-41BE-9866-BFAB4EB915BFQ54645627-AD868747-E5FD-4E6A-B02A-346156C61EA3Q55220517-85B17C58-6D5B-48B7-9789-DB1F23339D57Q58745106-3C57061F-8821-4128-95E6-280F8400D906
P2860
Targeting IGF-1 signaling pathways in gynecologic malignancies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting IGF-1 signaling pathways in gynecologic malignancies.
@en
type
label
Targeting IGF-1 signaling pathways in gynecologic malignancies.
@en
prefLabel
Targeting IGF-1 signaling pathways in gynecologic malignancies.
@en
P2860
P1476
Targeting IGF-1 signaling pathways in gynecologic malignancies.
@en
P2093
Haim Werner
Ilan Bruchim
P2860
P304
P356
10.1517/14728222.2013.749863
P407
P577
2013-01-07T00:00:00Z